Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS
Year: 1989
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal Of Haematology
Authors: A. Österborg, A. Ahre, M. Björkholm, M. Björeman, G. Brenning, G. Gahrton, H. Gyllenhammar, B. Johansson, G. Juliusson, M. Järnmark, A. Killander, E. Kimby, R. Lerner, B. Nilsson, C. Paul, B. Simonsson, A.‐M. Stalfelt, H. Strander, B. Smedmyr, E. Svedmyr, A.‐M. Udén, B. Wadman, C. Wedelin, H. Mellstedt
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2093084752